Literature DB >> 9335444

Effect of faecal occult blood testing on colorectal mortality: results of a population-based case-control study in the district of Florence, Italy.

M Zappa1, G Castiglione, G Grazzini, P Falini, D Giorgi, E Paci, S Ciatto.   

Abstract

The aim of our case-control study was to estimate the effect on mortality from colorectal cancer (CRC) of a population-based screening with a faecal occult blood test started in 1982 in a rural area of the district of Florence. We examined the relationship between mortality and the interval since the most recent screening. The cases in the study were 206 individuals who had died from CRC after the age of 41 years. Five controls were selected randomly from the list of individuals alive at the time of diagnosis of the corresponding case and were matched by sex, age and place and length of residence. After adjustment for potentially confounding factors, the odds ratio (OR) for death from CRC for screened persons vs. those not screened was 0.60 [95% confidence interval (CI), 0.4-0.9]. The OR was lowest in the first 3 years after the most recent test (OR = 0.54; 95% CI, 0.3-0.9) and increased towards unity subsequently. Our results suggest that screening for CRC by biennial faecal occult blood testing can reduce mortality from the disease.

Entities:  

Mesh:

Year:  1997        PMID: 9335444     DOI: 10.1002/(sici)1097-0215(19971009)73:2<208::aid-ijc8>3.0.co;2-#

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

1.  Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial.

Authors:  J H Scholefield; S Moss; F Sufi; C M Mangham; J D Hardcastle
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

Review 2.  Antagonist: population based endoscopic screening for colorectal cancer.

Authors:  D A L Macafee; J H Scholefield
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

Review 3.  Screening for colorectal cancer using the faecal occult blood test, Hemoccult.

Authors:  P Hewitson; P Glasziou; L Irwig; B Towler; E Watson
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

Review 4.  The impact of screening on colorectal cancer mortality and incidence: has it really made a difference?

Authors:  Ann G Zauber
Journal:  Dig Dis Sci       Date:  2015-03-05       Impact factor: 3.199

5.  Efficacy of screening using annual fecal immunochemical test alone versus combined with one-time colonoscopy in reducing colorectal cancer mortality: the Akita Japan population-based colonoscopy screening trial (Akita pop-colon trial).

Authors:  Hiroshi Saito; Shin-Ei Kudo; Noriaki Takahashi; Seiichiro Yamamoto; Kenta Kodama; Koichi Nagata; Yuri Mizota; Fumio Ishida; Yasuo Ohashi
Journal:  Int J Colorectal Dis       Date:  2020-02-07       Impact factor: 2.571

6.  The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer.

Authors:  M H Robinson; J D Hardcastle; S M Moss; S S Amar; J O Chamberlain; N C Armitage; J H Scholefield; C M Mangham
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

7.  Premature Fecal Immunochemical Testing in British Columbia Canada: a Retrospective Review of Physician and Screening Participant Characteristics.

Authors:  David Sanders; Brendan Bakos; Laura Gentile; Jennifer J Telford
Journal:  J Gen Intern Med       Date:  2019-12-12       Impact factor: 5.128

8.  Characteristics of Advanced Colorectal Cancer Detected by Fecal Immunochemical Test Screening in Participants with a Negative Result the Previous Year.

Authors:  Ryosuke Hasegawa; Kazuo Yashima; Yuichiro Ikebuchi; Shuji Sasaki; Akira Yoshida; Koichiro Kawaguchi; Hajime Isomoto
Journal:  Yonago Acta Med       Date:  2020-02-20       Impact factor: 1.641

9.  The IARC Perspective on Colorectal Cancer Screening.

Authors:  Béatrice Lauby-Secretan; Nadia Vilahur; Franca Bianchini; Neela Guha; Kurt Straif
Journal:  N Engl J Med       Date:  2018-03-26       Impact factor: 176.079

10.  Prevention of advanced colorectal cancer by screening using the immunochemical faecal occult blood test: a case-control study.

Authors:  M Nakajima; H Saito; Y Soma; T Sobue; M Tanaka; A Munakata
Journal:  Br J Cancer       Date:  2003-07-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.